Ovoca Bio plc
OVB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £400,562 | £780 | £4,492 | £14,055 |
| - Cash | £2,506 | £3,337 | £3,703 | £6,594 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £398,056 | -£2,557 | £789 | £7,461 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | £51 | -£549 | -£3,436 | -£5,776 |
| % Margin | – | – | – | – |
| Net Income | -£746 | -£4,702 | -£5,612 | -£5,475 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.063 | -0.069 | -0.067 |
| % Growth | 100% | 9% | -2.5% | – |
| Operating Cash Flow | -£1,136 | £1,115 | -£5,164 | -£4,376 |
| Capital Expenditures | £0 | -£49 | -£42 | -£171 |
| Free Cash Flow | -£1,136 | £1,066 | -£5,206 | -£4,547 |